GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,429.00p
   
  • Change Today:
      9.00p
  • 52 Week High: 2,263.00p
  • 52 Week Low: 1,296.00p
  • Currency: UK Pounds
  • Shares Issued: 4,094.93m
  • Volume: 8,105,348
  • Market Cap: £58,517m
  • RiskGrade: 129

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,821.00 4,800.00 119.40p 15.6 2.2 +7% 80.00p 4.3%
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 29,029.78 8,281.95 146.18p 9.8 2.1 +5% 56.03p 0.0%
31-Dec-24 30,939.51 8,785.54 156.10p 9.2 1.4 +7% 59.85p 0.0%
31-Dec-25 32,726.93 9,701.48 172.84p 8.3 0.8 +11% 64.37p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 15.61 10.29 16.10 0.64

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,429.00p
Change Today 9.00p
% Change 0.63 %
52 Week High 2,263.00p
52 Week Low 1,296.00p
Volume 8,105,348
Shares Issued 4,094.93m
Market Cap £58,517m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.66% below the market average69.66% below the market average69.66% below the market average69.66% below the market average69.66% below the market average
5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average
Price Trend
8.71% below the market average8.71% below the market average8.71% below the market average8.71% below the market average8.71% below the market average
36.51% above the sector average36.51% above the sector average36.51% above the sector average36.51% above the sector average36.51% above the sector average
Income
38.53% above the market average38.53% above the market average38.53% above the market average38.53% above the market average38.53% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Growth
52.17% below the market average52.17% below the market average52.17% below the market average52.17% below the market average52.17% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average

What The Brokers Say

Strong Buy 3
Buy 6
Neutral 13
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 31-Mar-2023

Time Volume / Share Price
17:39 9,786 @ 1,432.28p
17:39 13,639 @ 1,432.26p
17:39 13,947 @ 1,428.99p
17:39 15,224 @ 1,428.99p
17:39 18,335 @ 1,431.99p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page